Loomis, Sayles & Company’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-231
| Closed | -$5K | – | 1152 |
|
|
2016
Q3 | $5K | Sell |
231
-529,161
| -100% | -$11.5M | ﹤0.01% | 897 |
|
|
2016
Q2 | $15.3M | Sell |
529,392
-20,037
| -4% | -$577K | 0.04% | 341 |
|
|
2016
Q1 | $17.6M | Sell |
549,429
-2,235
| -0.4% | -$71.6K | 0.05% | 305 |
|
|
2015
Q4 | $23.6M | Buy |
551,664
+60,163
| +12% | +$2.57M | 0.07% | 228 |
|
|
2015
Q3 | $17.3M | Buy |
491,501
+5,442
| +1% | +$192K | 0.05% | 320 |
|
|
2015
Q2 | $22.3M | Buy |
486,059
+59,908
| +14% | +$2.75M | 0.06% | 293 |
|
|
2015
Q1 | $20M | Sell |
426,151
-86,044
| -17% | -$4.03M | 0.06% | 332 |
|
|
2014
Q4 | $16.2M | Buy |
512,195
+57,872
| +13% | +$1.83M | 0.05% | 400 |
|
|
2014
Q3 | $10.8M | Sell |
454,323
-178,779
| -28% | -$4.24M | 0.03% | 477 |
|
|
2014
Q2 | $19M | Buy |
+633,102
| New | +$19M | 0.05% | 366 |
|